Suzhou Pharma Services, an affiliate of Amerigen Pharmaceuticals, a new contract development and manufacturing organization specializing in solid oral dosage forms, recently announced its new corporate headquarters in Lyndhurst, NJ, and the company’s primary manufacturing facility located in Suzhou, China.
Suzhou Pharma Services is one of China‘s first US FDA-approved and Chinese SFDA-licensed finished product cGMP manufacturing sites. Suzhou‘s corporate US office includes the Senior Management Team, R&D, Regulatory Affairs and Quality Heads, a US-based Product Development and Project Management Team, and Business Development.
The management team in China is composed of highly experienced, Western trained leaders, averaging 20 plus years experience with multi-national branded and generic pharmaceutical companies. The company’s mission at Suzhou Pharma Services is to provide customers innovative and reliable solutions to their oral solid dose development and manufacturing needs, under the highest levels of quality and customer service standards available in the industry. It is solely focused on solid oral dosages with a highly skilled and trained workforce. The customer service and project teams are locally based in the US, facilitating all interactions and acting as a conduit for client communications.
It combines Western pharmaceutical experience, expertise, and quality standards with Chinese productivity and cost advantages, offering a very attractive volume proposition to global customers.
Suzhou Pharma Services can deliver to pharmaceutical manufactures’ not only cost savings and high-quality products for Western and Global Markets, but also a local manufacturing solution for access to the growing Chinese pharmaceutical marketplace. For more information, visit www.suzhoupharma.com or email at info@suzhoupharma.com.
